Literature DB >> 385703

Pathogenesis of neonatal Graves' disease.

J M McKenzie, M Zakarija.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 385703     DOI： 10.1007/BF03350370

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  31 in total

1.  Neonatal hyperthyroidism following intrauterine hypothyroidism.

Authors:  A Hayek; M Brooks
Journal:  J Pediatr       Date:  1975-09       Impact factor: 4.406

2.  ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA.

Authors:  J P KRISS; V PLESHAKOV; J R CHIEN
Journal:  J Clin Endocrinol Metab       Date:  1964-10       Impact factor: 5.958

3.  Juvenile thyrotoxicosis treated with propyl thiouracil and two subtotal thyroidectomies.

Authors:  L D ALTMAN
Journal:  J Pediatr       Date:  1950-02       Impact factor: 4.406

4.  Recovery of the long-acting thyroid stimulator from serum of patients with thyrotoxicosis by concentration of immunoglobulin G.

Authors:  L Carneiro; K J Dorrington; D S Munro
Journal:  Clin Sci       Date:  1966-10       Impact factor: 6.124

5.  Thyroid-stimulating immunoglobulins in Graves' disease.

Authors:  B R Smith; R Hall
Journal:  Lancet       Date:  1974-08-24       Impact factor: 79.321

6.  Hereditary aspects of Graves' disease in infancy and childhood.

Authors:  D R Hollingsworth; C C Mabry; J M Eckerd
Journal:  J Pediatr       Date:  1972-09       Impact factor: 4.406

7.  Neonatal thyrotoxicosis associated with maternal hypothyroidism.

Authors:  J A Thomson; I D Riley
Journal:  Lancet       Date:  1966-03-19       Impact factor: 79.321

8.  Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.

Authors:  L M Lipman; D E Green; N J Snyder; J C Nelson; D H Solomon
Journal:  Am J Med       Date:  1967-10       Impact factor: 4.965

9.  Placental transmission of thyroid-stimulating immunoglobulins.

Authors:  S M Dirmikis; D S Munro
Journal:  Br Med J       Date:  1975-06-21

10.  Characteristics of thyrotropin binding to bovine thyroid plasma membranes and the influence of human IgG.

Authors:  A Sato; M Zakarija; J M McKenzie
Journal:  Endocr Res Commun       Date:  1977
View more
  6 in total

1.  Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.

Authors:  J Ginsberg; C von Westarp
Journal:  CMAJ       Date:  1986-05-15       Impact factor: 8.262

2.  Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.

Authors:  P Heyma; L C Harrison
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

3.  Autoimmune thyroid disease and pregnancy.

Authors:  A M McGregor; R Hall; C Richards
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-16

4.  Thyroid hormone secretion is more sensitive than thyroid cyclic AMP accumulation to stimulation with LATS in mice in vitro and in vivo.

Authors:  H Ikeda; S C Chiu; N Kuzuya; H Uchimura; S Nagataki
Journal:  J Endocrinol Invest       Date:  1984-02       Impact factor: 4.256

5.  Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.

Authors:  M Zakarija; J M McKenzie; D S Munro
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

6.  The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.

Authors:  H Bliddal; K Bech; K Siersbaek-Nielsen; T Friis
Journal:  J Endocrinol Invest       Date:  1983-08       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.